Pharmaceutical Companies Providing Medical Education Grants
The evidence provided does not contain specific guidelines or systematic information about which pharmaceutical companies provide medical education grants. However, based on conflict of interest disclosures from multiple medical society guidelines, the following pharmaceutical companies consistently provide funding for medical education, research grants, and continuing medical education (CME) programs:
Major Pharmaceutical Companies Providing Educational Support
Respiratory/Pulmonary Medicine
- GlaxoSmithKline (GSK) provides research grants, unrestricted educational grants, and CME sponsorship 1
- Boehringer Ingelheim sponsors conferences, provides research grants, and funds continuing education 1
- AstraZeneca funds research, sponsors conferences, and provides educational support 1
- Pfizer provides speaker training, conference sponsorship, and research funding 1
- Novartis offers research grants and educational funding 1
- Merck/Merck Sharp & Dohme provides educational grants and research support 1
HIV/Infectious Disease Medicine
- Gilead Sciences provides institutional grants and research funding 1
- ViiV Healthcare offers research grants and consulting arrangements 1
- Janssen provides grants and consulting fees 1
Additional Companies
- Altana Pharma sponsors advisory boards and research 1
- Sunovion Pharmaceuticals provides research grants and speaker bureau support 1
- Abbott Laboratories funds conferences and advisory committees 1
- Genentech provides research support and educational grants 1
- Centocor offers research grants 1
Important Context About Industry-Sponsored Medical Education
The pharmaceutical industry funds approximately 50% of continuing medical education (CME) costs in the United States 2, with the industry expecting to recoup $3.56 in increased sales for every dollar invested in CME 2. This creates inherent conflicts of interest that affect physician prescribing behavior 3.
Key Concerns
- Drug company-sponsored CME preferentially highlights the sponsor's medications compared to non-sponsored programs 3
- Attending industry-sponsored events is associated with increased prescription rates of the sponsor's medication 3
- Commercial bias is highly visible at large CME gatherings 2
Regulatory Oversight
The Accreditation Council for Continuing Medical Education (ACCME) instituted guidelines in 2004 to reduce commercial influence, requiring firewalls between CME funding and drug marketing 2. The Department of Health and Human Services has warned about possible anti-kickback violations without proper separation 2.